Stock Market Today (11 August 2026): Manappuram Profit Soars 4x, Siemens Order Book Hits Record High

Q1 earnings season kept its pace on Dalal Street today, and the standout theme was scale — companies reporting either outsized profit jumps or order books running into tens of thousands of crores. Manappuram Finance led the gainers with a fourfold profit surge and a mega fundraising plan, Siemens posted a record order backlog even as its core profit came under pressure, and Zydus Lifesciences balanced a profit decline with a sizeable share buyback. Godrej Consumer's leadership transition and Vodafone Idea's narrowing losses added to a session that had something for nearly every sector.

Manappuram Finance Rockets on Gold Loan Growth

Manappuram Finance was the session's biggest earnings story. Profit soared to ₹585 crore, up from ₹140 crore a year earlier, a jump reported at both 4x and 341% year-on-year across filings, with revenue reaching ₹3,034 crore on the back of strong gold loan growth. The board declared a ₹1 dividend and approved a fundraising plan of up to ₹1 lakh crore, giving the non-bank lender significant headroom to expand its loan book.

Siemens' Order Book Swells to ₹45,030 Crore, Core Profit Slips

Siemens reported a profit that looks spectacular on the surface — up roughly fivefold — but the underlying picture is more layered. The headline number was boosted by a ₹2,099 crore gain from discontinued operations, while profit from continuing operations actually fell to ₹343 crore. Revenue came in between ₹4,195 crore and ₹4,714 crore depending on the segment reported, with pre-tax profit at ₹434 crore.

What stood out beyond the quarter itself was the order backlog, which touched ₹45,030 crore, and a stock that is already up 28% year-to-date. The company declared an ₹18 dividend for FY26 at its 68th AGM, rewarding shareholders even as the core earnings line stayed under pressure.

Zydus Lifesciences Announces Buyback as Q1 Profit Slips

Zydus Lifesciences posted a Q1 profit of ₹940 crore, down 36% year-on-year, even though revenue climbed roughly 21-22% to about ₹8,000 crore. The board approved a buyback worth ₹1,106 crore, a move that tends to cushion sentiment when the profit line disappoints.

The company also flagged a rule violation and transferred ₹18,797 in forfeited profit to the Investor Education and Protection Fund, disclosed a ₹1,600 crore capex plan for FY27, and secured global rights to Alvelestat through a $40 million licensing deal with Mereo. The stock had risen 7% on the results, and Macquarie raised its target to ₹1,285, pointing to MedTech and direct-to-consumer growth potential.

Vodafone Idea's Losses Narrow as ARPU Momentum Builds

Vodafone Idea's quarter continued its recent pattern of operational improvement without a return to profitability. The loss narrowed from the prior quarter, ARPU rose for a third consecutive quarter, and EBITDA crossed ₹5,000 crore for the first time in this run. Brokerages stayed cautious on valuation even as the trend improved — JPMorgan held its target at ₹9 despite the beat, while CLSA kept a Hold rating with a ₹13 target, citing ongoing debt concerns.

Godrej Consumer Names New CEO as Sitapati Steps Down

Godrej Consumer Products confirmed a leadership change, with Sudhir Sitapati resigning shortly after his reappointment and Aasif Malbari named as the new CEO. The company said it is targeting Africa margins of 15% by FY26 under the new leadership. The stock has outperformed the Nifty FMCG index through the transition, suggesting the market has taken the succession in stride so far.

Kalpataru Projects' Order Book Crosses ₹66,000 Crore

Kalpataru Projects reported a 45% jump in Q1 profit to ₹310 crore, with margins improving alongside the earnings growth. The order book now stands at ₹66,607 crore, and the board approved a ₹150 crore expansion of its Raipur mill. Despite labor-related challenges flagged during the results call, the company kept its FY27 revenue target of ₹30,000 crore intact.

Sector Watch: Consumer, Power & Infra, and Pharma

Consumer and retail names had a broadly positive session. Bata India's profit rose 23% with a ₹25 dividend declared, Matrimony.com's profit jumped 126% on 2.72 lakh new subscriptions even as its CFO resigned, and Lumax Auto Technologies more than doubled its profit, up 109%, on the back of a new Maharashtra plant announcement.

Power and infrastructure names were mixed. Gujarat Energy's profit rose 70-78% to around ₹998 crore on city gas distribution and gas trading gains, with CARE reaffirming its AAA rating, and NBCC's profit beat estimates with a 17% rise despite a revenue dip. On the softer side, KEC International fell 4% on a weak quarter and flagged West Asia-related and labor disruptions, Star Cement lowered its FY27 growth target citing Assam flood disruption, and KPI Green Energy's profit fell 14-15% even after bagging a 500 MW NTPC order.

In pharma, Gland Pharma jumped 10% on a Q1 beat, though brokerages remain split — Jefferies rates it Buy with a ₹3,350 target while Goldman Sachs keeps a Sell at ₹2,125. Akums Drugs is targeting EBITDA-positive API operations by FY27 after winning a ₹240 crore Zambia order, while Fermenta Biotech's profit fell 56% on margin pressure.

Market Outlook

Today's session reinforced a familiar pattern this earnings season: strong headline numbers often come with caveats, and investors are having to look past one-off items to judge underlying trends. Manappuram's fundraising plan, Siemens' order backlog and Kalpataru's swelling order book all point to capex and lending appetite that could support growth into FY27.

Set against that, profit declines at Zydus, Fermenta, KPI Green and KEC, along with ongoing margin pressure flagged by MRF and Balrampur Chini, suggest the earnings picture is far from uniformly strong. Vodafone Idea's debt overhang persists despite the operational improvement, and Zee Entertainment's brokerage views range from a ₹80 Sell to a ₹125 Outperform, underscoring how divided opinion remains on some names.